The AF-1 and AF-2 activating domains of retinoic acid receptor-α (RARα) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes

Molecular Endocrinology

Volumn 14, Issue 9, 2000, Pages 1398-1410

  Rochette Egly, Cecile ^a,b   Plassat, Jean Luc ^a   Taneja, Reshma ^a,c   Chambon, Pierre ^a  

^a l'alimentation et l'Environnement   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; ENDODERM; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033755402     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.9.0527     Document Type: Article

References (52)

1. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP
2. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells
3. Retinoids and vertebrate development
4. The induction of differentiation in teratocarcinoma cells by retinoic acid
5. Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2)
6. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids
7. Specific and redundant functions of retinoid X receptor/retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells
8. A decade of molecular biology ot retinoic acid receptors
9. The nuclear receptor superfamily: The second decade
10. Multiplicity generates diversity in the retinoic acid signalling pathways
11. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
12. Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin
13. The expression of retinoid X receptor genes is regulated by all-trans- and 9-cis-retinoic acid in F9 teratocarcinoma cells
14. Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR α or RAR β in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types
15. Loss of retinoic acid receptor γ function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment
16. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism
17. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand
18. Cell-type and promotercontext dependent retinoic acid receptor (RAR) redundancies for RAR β2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts
19. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells
20. Phosphorylation of activation functions AF-1 and AF-2 of RAR α and RAR γ is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment
21. RARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo
22. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors
23. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity
24. The retinoic acid receptor-β2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain
25. A new version of the two-hybrid assay for detection of protein-protein interactions
26. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
27. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
28. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
29. A canonical structure for the ligand-binding domain of nuclear receptors
30. Nuclear receptor coactivators
31. The nuclear receptor ligand-binding domain: Structure and function
32. Stimulation of RAR α activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7
33. Hyperphosphorylation of the retinoid X receptor α (RXRα) by activated c-Jun N-terminal kinases (JNKs)
34. Phosphorylation of the retinoic acid receptor-α by protein kinase A
35. TFIIH interacts with the retinoic acid receptor γ (RARγ), phosphorylates its AF-1 activating domain through cdk7
36. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
37. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells
38. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene
39. Retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells
40. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and retinoid X receptor α
41. Coactivator and corepressor complexes in nuclear receptor function
42. The coregulator exchange in transcriptional functions of nuclear receptors
43. CREB-binding protein activates transcription through multiple domains
44. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation
45. Dominant negative mutant of retinoic acid receptor α inhibits retinoic acid-induced P19 cell differentiation by binding to DNA
46. The conserved amphipatic α-helical core motif of RARγ, RAR αAF-2 activating domains is indispensable for RA-induced differentiation of F9 cells
47. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter
48. Retinoic acid receptor gamma: Specific immunodetection and phosphorylation
49. Immunodetection of multiple species of retinoic acid receptor α: Evidence for phosphorylation
50. The mouse homologue of the human acidic ribosomal phosphoprotein PO: A highly conserved polypeptide that is under translational control
51. The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells
52. Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos